Related Experiment Videos
Bovine hydroxyapatite orbital implant: a preliminary report
Julian D Perry1, Robert Alan Goldberg, John D McCann
1Department of Ophthalmic Plastics and Orbital Surgery, Division of Ophthalmology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. perryj1@ccf.org
Ophthalmic Plastic and Reconstructive Surgery
|July 27, 2002
Summary
Bovine hydroxyapatite is a safe and effective material for orbital implants, showing good biocompatibility and allowing for fibrovascular integration and motility peg placement in patients.
Area of Science:
- Ophthalmology
- Biomaterials Science
- Surgical Innovation
Background:
- Orbital implants are crucial for restoring aesthetics and function after orbital exenteration.
- Traditional implant materials face challenges with biocompatibility and integration.
- Bovine hydroxyapatite presents a novel biomaterial for orbital reconstruction.
Purpose of the Study:
- To evaluate the safety and efficacy of bovine hydroxyapatite as an orbital implant.
- To assess the biocompatibility and integration of this novel material.
- To determine complication rates and functional outcomes.
Main Methods:
- Prospective case series of 27 patients undergoing orbital implantation.
- Inclusion criteria: enucleation, evisceration, or secondary orbital implantation.
- Follow-up included clinical assessment and magnetic resonance imaging (MRI) for fibrovascular ingrowth.
Main Results:
- Bovine hydroxyapatite demonstrated good biocompatibility with minimal complications (chemosis, exposure).
- MRI confirmed progressive fibrovascular ingrowth, with 67% complete ingrowth by 4-12 months.
- Successful motility peg placement was achieved in 5 patients.
Conclusions:
- Bovine hydroxyapatite is a safe and effective orbital implant material.
- The material exhibits excellent biocompatibility and promotes fibrovascular integration.
- It supports motility peg placement, enhancing functional outcomes.